Zobrazeno 1 - 10
of 518
pro vyhledávání: '"K Alimoghaddam"'
Autor:
F Nadali, Sh Ferdowsi, B Chardouli, GR Togheh, N Einollahi, SA Mousavi, K Alimoghaddam, A Ghavamzadeh, SH Ghaffari
Publikováno v:
پیاورد سلامت, Vol 2, Iss 3, Pp 16-25 (2008)
Background and Aim : Myeloproliferative neoplasms are clonal and heterogeneous disorders of hematopoietic stem cells lead to increase of one or more cell lines in the blood. Recently, the acquired mutation JAK2 V617F has been described in the majorit
Externí odkaz:
https://doaj.org/article/903b01490a094576bec0bd7cb2ce2b00
Autor:
K Alimoghaddam, SA Mousavi, N Einollahi, GR Togheh, B Chardouli, Sh Ferdowsi, A Ghavamzadeh, F Nadali, SH Ghaffari
Publikováno v:
پیاورد سلامت, Vol 2, Iss 3, Pp 16-25 (2008)
Background and Aim : Myeloproliferative neoplasms are clonal and heterogeneous disorders of hematopoietic stem cells lead to increase of one or more cell lines in the blood. Recently, the acquired mutation JAK2 V617F has been described in the majorit
Externí odkaz:
https://doaj.org/article/c9323c41e82d4ecdbefb18856821e67b
Autor:
MR Khorramizadeh, F Saadat, H Allahyary, S Sadeghian, A Sarrafnejad, A Mirshafiey, F Safavifar, K Alimoghaddam, A Ghavamzadeh, M Pezeshki
Publikováno v:
Iranian Journal of Public Health, Vol 35, Iss 1, Pp 17-24 (2006)
Recent evidences suggest that multiple myeloma phenotypes (MMPs) are involved in the infiltration of multiple myeloma-affected marrow foci. In this study, the effects of arsenic trioxide on the invasive and angiogenic phenotypes of multiple myeloma (
Externí odkaz:
https://doaj.org/article/c9239c757dc04dd6bb94c9ccaf757a68
Autor:
M Yaghmaie, S.H Ghaffari, K Alimoghaddam, A Ghavamzadeh, S.A Mousavi, M Irvani, B Bahar, E Bibordi, M Jahani
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 2, Iss 3 (2005)
Introduction: Reverse transcriptase-polymerase chain reaction (RT-PCR) assay is a useful tool for the detection of fusion transcript resulting from specific chromosomal translocation of the leukemia cells. A specific chromosomal abnormality, the Phil
Externí odkaz:
https://doaj.org/article/d389918232474ecaa7a8a13fce20a420
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 2, Iss 3 (2005)
Introduction: Quantification of Epstein - Barr virus (EBV) in peripheral blood mononuclear cells (PBMNC) of allogenic bone marrow transplant (BMT) recipients is important because EBV-associated posttransplant Lymphoproliferative disease (PTLD) can oc
Externí odkaz:
https://doaj.org/article/f661d488aefc40e2982512816fd26f19
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 2, Iss 2 (2005)
Background: Cisplatin-based chemotherapy is the standard treatment for advanced non-small cell lung cancer (NSCLC). Many novel drugs, including gemcitabine, vinorelbine, paclitaxel and docetaxel have been used in combination with cisplatin in this se
Externí odkaz:
https://doaj.org/article/3392f90b0e2d48439720cdb36973bbc9
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 2, Iss 2 (2005)
Mesenchyml stem cell (MSC) are receiving much attention in treatment of various diseases. The low frequency of MSCs in bone marrow (BM) necessitates their in vitro expansion prior to clinical use. We evaluated the effect of long term culture on the s
Externí odkaz:
https://doaj.org/article/45d81acf823946f7bf1c6e371299ddf6
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 2, Iss 2 (2005)
Objective: To evaluate the potential advantages of imipenem/cilastatin in control of fever in neutro-penic HSCT recipients.Patients and Method: In this single-center study, 111 consecutive febrile episodes in 104 neutropenic HSCT recipients with a me
Externí odkaz:
https://doaj.org/article/7ebffbf08ba34cbe9ea560cdd800d0de
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 2, Iss 1 (2005)
Objective: Mesenchymal stem cells (MSC) are capable of self-renewal and differentiation into various connective tissue lineages. Therefore, they have attracted a lot of attention from investigators in the context of stem cell therapies. In our study,
Externí odkaz:
https://doaj.org/article/6657c99b3d924de5a90ef04bc013b300
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 1, Iss 2 (2004)
Background: Acute Promyelocytic Leukemia is a sub-type of acute myelogenous leukemia that occurs in about 10-15% of patients with AML. Approximately 20%-30% of these patients, who are treated with the current standard All Trans Retinoic Acid (ATRA) a
Externí odkaz:
https://doaj.org/article/5ffb09ca647a4e6aa9e58d9783b19eff